Evaluation of Anticancer and Antibacterial Activities for Pluronic F-127 Encapsulated Magnesium Oxide Nanoparticles Using Alstoniayunnanensis Leaf Extract

Primary brain tumors caused by gliomas are most frequently found in the neurons of the central nervous system. The present study explores the effects of Pluronic F-127 coated magnesium oxide nanoparticles (PF-127 MgO NPs) using Alstonia yunnanensis leaf extract (A. yunnanensis) on C6 glioma cells (C6 cells). The vital part of nanotechnology is the formulation of environmentally friendly methods for making NPs. Because of their small size, NPs can pass easily through the holes in intracellular cell membranes and into living tissue. Numerous integrated protein therapies have shown enhanced medicinal qualities and thermo stability owing to PF-127. MgO is employed in cell therapy, tissue repair and the creation of cancer medicines. In this research, we synthesized PF-127 MgO NPs using A. yunnanensis leaf extract to study the activity of their anti-bacterial and anti-cancer activities on C6 cells. We examined the synthesized NPs by the UV-Vis, FT-IR, PL, TEM, SAED, FE-SEM, EDAX, XRD, and DLS techniques. The anti-bacterial effectiveness and anti-cancer activity C6 cells on MTT assay, AO/EtBr, DAPI, DCFH-DA and Rh-123 staining methods of synthesized PF-127 MgO NPs. Moreover, the synthesized NPs characterization studies can be used high activity anti-bacterial and significant anti-cancer activity were noticed. The study finds that the NPs increased ROS accumulation and resulting in apoptotic cell death. Overall, our findings show that synthesized PF-127 coated MgO NPs using A. yunnanensis leaf extract possess anti-bacterial and anti-cancer properties in C6 cells.